×
Home
Archive Submission Guidelines
News Contact
Review article
Crossmark

The role of neuroplasticity in the etiology and treatment of depressive disorders

By
Ina Konstantinović ,
Ina Konstantinović

Klinički centar Niš , Niš , Serbia

Milena Trandafilović Orcid logo
Milena Trandafilović

University of Nis , Niš , Serbia

Abstract

Depression is a mood disorder that prevents the patients from performing everyday activities, due to the constant presence of negative feelings. Depression is a worldwide medical disorder which is highly prevalent and has therefore become a huge financial burden for the health system. Biological, psychological, and social factors are most commonly described in the pathophysiology of depressive disorders, although the mechanisms behind depression are still not fully understood. Neuroplasticity is the ability of the nervous system to reorganize its structure and function in response to different stimuli. The aim of this paper was to summarize the available literature on neuroplasticity and its role in the pathophysiology and treatment of depressive disorders. Depression is often accompanied by chronic illnesses and is more prevalent in women than men. The most commonly used treatment options for depressive disorders are antidepressants, electroconvulsive therapy, and psychosocial therapy. Neuroplasticity has led to the development of a new clinical discipline called neurorehabilitation, and recent studies have shown a possible link between neuroplasticity and depression. It has been observed that different mechanisms behind neuroplasticity affect the structure of the limbic and paralimbic structures, especially the hippocampus, prefrontal cortex, and amygdala. Limbic and paralimbic structures also undergo structural changes in depressed patients treated with electroconvulsive therapy and medications, which could lead to a better understanding of depressive disorders and how they should be treated.

References

1.
American Psychiatric Association: Diagnostic and statistical manual of mental disorders. 2000;
2.
Christensen MC, Wong CMJ, Baune BT. Symptoms of Major Depressive Disorder and Their Impact on Psychosocial Functioning in the Different Phases of the Disease: Do the Perspectives of Patients and Healthcare Providers Differ? Frontiers in Psychiatry. 11.
3.
Ménard C, Hodes GE, Russo SJ. Pathogenesis of depression: Insights from human and rodent studies. Neuroscience. 2016;321:138–62.
4.
Briley M, Chantal M. The importance of norepinephrine in depression. Neuropsychiatric Disease and Treatment. :9.
5.
Penner-Goeke S, Binder EB. Epigenetics and depression. Dialogues in Clinical Neuroscience. 2019;21(4):397–405.

Citation

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.